Novartis shareholder calls for board shake-up after trial setbacks
A major shareholder in Novartis called for changes to the Swiss drugmaker’s board to improve corporate governance. The appeal follows back-to-back trial setbacks and a record share fall this week.
A major Novartis shareholder has called for changes to the Swiss drugmaker’s board to improve corporate governance after the stock suffered a record decline this week following back-to-back trial setbacks. David Samra, managing director at Artisan Partners, said the company needs a board shake-up after the recent setbacks.